When non-Hodgkin’s lymphoma returns


Breakthrough research: Major advancements in the understanding of diffuse large B cell lymphoma has led to many new therapies developed to treat it, including CAR-T cell therapy, which is being researched in this French pharmaceutical lab. — AFP

LYMPHOMA is a type of cancer that originates from lymphocytes, a type of white blood cell.

It can be broadly classified to two main groups: Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
lymphoma , cancer , Dr Edmund Chin

Next In Columnists

Respecting rights of the elderly
Man of the Hour
Malaysia’s Innovation Paradox: Rising Aspirations, Declining Foundations
Respect can build nations
Red cards, redemption and rising pressure across Premier League
Riding the tide: Malaysia-China collaboration in the blue economy
Sabah polls a wake-up call to Putrajaya
The governance conundrum
Sabah polls produces a few shockers
Turning cancer adversity into health opportunity

Others Also Read